baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC WAR. CALL 06/24 PFE/ DE000HC6V2K9 /

5/22/2024 1:42:04 PM	Chg.-0.0010	Bid5/22/2024	Ask-	Underlying	Strike price	Expiration date	Option type
0.0010EUR	-50.00%	0.0010 Bid Size: 100,000	- Ask Size: -	PFIZER INC. D...	35.00 -	6/19/2024	Call

GlobeNewswire 5/21 Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™...

GlobeNewswire 5/21 Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer

GlobeNewswire 5/16 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...

TeleTrader 5/1 Pfizer's Q1 revenue drops 20% to $14.9 billion

GlobeNewswire 4/30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...

GlobeNewswire 3/22 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...

GlobeNewswire 3/20 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire 3/7 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 3/7 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 3/5 LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd...

GlobeNewswire 2/28 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 2/28 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 2/27 Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment t...

GlobeNewswire 2/23 Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market

GlobeNewswire 2/20 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 2/16 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...

GlobeNewswire 2/11 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 2/8 ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Importan...

GlobeNewswire 2/6 Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment o...

GlobeNewswire 2/3 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

TeleTrader 1/30 Pfizer posts Q4 revenue of $14B, reaffirms guidance

GlobeNewswire 1/26 ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadl...

GlobeNewswire 1/26 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 1/18 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

UC WAR. CALL 06/24 PFE/ DE000HC6V2K9 /

If you wish to receive reply to your feedback, please provide your email address.